BiondVax Pharmaceuticals (NASDAQ:BVXV) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research report report published on Thursday morning. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Down 0.7 % Shares of BVXV opened at $1.38 on Thursday. BiondVax Pharmaceuticals has a 52 week low of $1.29 and a […]

Related Keywords

Israel , ,Envestnet Asset Management Inc ,News Ratings For Biondvax Pharmaceuticals Daily ,Biondvax Pharmaceuticals Ltd ,Max Planck Society ,University Medical Center ,Biondvax Pharmaceuticals Company Profile ,Biondvax Pharmaceuticals ,Nasdaq ,Biondvax Pharmaceuticals Stock Down ,Free Report ,Vax Pharmaceuticals Stock Down ,Vax Pharmaceuticals ,Asset Management ,Vax Pharmaceuticals Ltd ,Biondvax Pharmaceuticals Daily ,Nasdaq Bvxv ,Bvxv ,Medical ,Initiated Coverage ,Stocknews Com ,